{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:56:54Z","timestamp":1790895414148,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejso.2026.112175","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:46:12Z","timestamp":1790379972000},"page":"112175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) versus palliative chemotherapy for peritoneal metastasized gastric cancer: a propensity score matched analysis"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7057-0274","authenticated-orcid":false,"given":"Lianne","family":"Triemstra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5869-6296","authenticated-orcid":false,"given":"Halit","family":"Topal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1371-442X","authenticated-orcid":false,"given":"Annouschka","family":"Laenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9230-1158","authenticated-orcid":false,"given":"Emma C.","family":"Gertsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4573-9143","authenticated-orcid":false,"given":"Hylke J.F.","family":"Brenkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4688-2921","authenticated-orcid":false,"given":"Nadia Haj","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9678-1611","authenticated-orcid":false,"given":"Rob H.A.","family":"Verhoeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelmina M.U.","family":"van Grevenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle P.","family":"Ruurda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Sagaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7692-4419","authenticated-orcid":false,"given":"Wim","family":"Ceelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2687-7535","authenticated-orcid":false,"given":"Baki","family":"Topal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7134-261X","authenticated-orcid":false,"given":"Richard","family":"van Hillegersberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejso.2026.112175_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejso.2026.112175_bib2","series-title":"Richtlijn maagcarcinoom","year":"2023"},{"key":"10.1016\/j.ejso.2026.112175_bib3","first-page":"53","article-title":"Peritoneal-plasma barrier","volume":"vol. 82","author":"Jacquet","year":"1996"},{"issue":"9","key":"10.1016\/j.ejso.2026.112175_bib4","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","article-title":"Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy","volume":"17","author":"Glehen","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112175_bib5","series-title":"Update van de praktijkrichtlijn voor slokdarm- en maagkanker","author":"Lerut","year":"2012"},{"issue":"6","key":"10.1016\/j.ejso.2026.112175_bib6","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1245\/s10434-015-5081-3","article-title":"Patients with peritoneal carcinomatosis from gastric cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is cure a possibility?","volume":"23","author":"Chia","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112175_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejso.2013.10.019","article-title":"Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials","volume":"40","author":"Coccolini","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2026.112175_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jso.23633","article-title":"Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial","volume":"110","author":"Rudloff","year":"2014","journal-title":"J Surg Oncol"},{"issue":"10184","key":"10.1016\/j.ejso.2026.112175_bib9","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"Al-Batran","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2026.112175_bib10","series-title":"Woodbury: Cine-Med","first-page":"1","article-title":"Cytoreductive surgery & perioperative chemotherapy for peritoneal surface malignancy","author":"Sugarbaker","year":"2012"},{"issue":"10","key":"10.1016\/j.ejso.2026.112175_bib11","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/bjs.9582","article-title":"Consensus guidelines for enhanced recovery after gastrectomy: enhanced Recovery after Surgery (ERAS\u00ae) Society recommendations","volume":"101","author":"Mortensen","year":"2014","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.ejso.2026.112175_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"issue":"3","key":"10.1016\/j.ejso.2026.112175_bib13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"1","key":"10.1016\/j.ejso.2026.112175_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4780-0","article-title":"Prognostic value of differentiation status in gastric cancer","volume":"18","author":"Feng","year":"2018","journal-title":"BMC Cancer"},{"issue":"408","key":"10.1016\/j.ejso.2026.112175_bib15","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1080\/01621459.1989.10478874","article-title":"The Robust inference for the Cox proportional hazards model","volume":"84","author":"Lin","year":"1989","journal-title":"J Am Stat Assoc"},{"issue":"12","key":"10.1016\/j.ejso.2026.112175_bib16","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2026.112175_bib17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/bjs.8679","article-title":"Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer","volume":"99","author":"Segelman","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2026.112175_bib18","series-title":"Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin A population-based Study","author":"Thomassen","year":"2012"},{"issue":"8","key":"10.1016\/j.ejso.2026.112175_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.30018","article-title":"Incidence, stage, treatment, and survival of noncardia gastric cancer","volume":"6","author":"van Velzen","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.ejso.2026.112175_bib20","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S1470-2045(23)00396-0","article-title":"Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial","volume":"24","author":"Aronson","year":"2023","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2026.112175_bib21","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112175_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-017-3730-6","article-title":"Cytoreductive surgery and Hyperthermic intra-operative peritoneal chemotherapy with Cisplatin for gastric peritoneal Carcinomatosis Monocentric phase-2 nonrandomized prospective clinical trial","volume":"17","author":"Topal","year":"2017","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2026.112175_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10120-019-00978-0","article-title":"Peritoneal metastasis in gastric cancer: results from the German database","volume":"23","author":"Rau","year":"2020","journal-title":"Gastric Cancer"},{"issue":"8","key":"10.1016\/j.ejso.2026.112175_bib24","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1245\/s10434-019-07450-4","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric cancer with peritoneal carcinomatosis: Multicenter Study of Spanish Group of peritoneal oncologic surgery (GECOP)","volume":"26","author":"Manzanedo","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"10.1016\/j.ejso.2026.112175_bib25","doi-asserted-by":"crossref","first-page":"9060","DOI":"10.1245\/s10434-021-10157-0","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer with synchronous peritoneal metastases: Multicenter Study of \u2018Italian Peritoneal Surface Malignancies Oncoteam\u2014S.I.C.O.\u2019","volume":"28","author":"Marano","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2026.112175_bib26","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1007\/s10120-019-00969-1","article-title":"The efficacy of treatment options for patients with gastric cancer and peritoneal metastasis","volume":"22","author":"Rau","year":"2019","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejso.2026.112175_bib27","article-title":"Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer with intraoperative detection of limited peritoneal metastasis: a Phase II study of CLASS-05 trial","volume":"12","author":"Lin","year":"2024","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.ejso.2026.112175_bib28","article-title":"Survival outcomes of cytoreductive surgery with HIPEC in gastric adenocarcinoma: a national cancer database Study","volume":"1","author":"Khomiak","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.112175_bib29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1200\/JCO.22.02867","article-title":"Effect of hyperthermic intraperitoneal chemotherapy on cytoreductive surgery in gastric cancer with synchronous peritoneal metastases: the phase III GASTRIPEC-I trial","volume":"42","author":"Rau","year":"2024","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112175_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5640-2","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)","volume":"19","author":"Koemans","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2026.112175_bib31","author":"Quik","year":"2026","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2026.112175_bib32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lungcan.2020.08.018","article-title":"Nationwide effect of high procedure volume in lung cancer surgery on in-house mortality in Germany","volume":"149","author":"Baum","year":"2020","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.ejso.2026.112175_bib33","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s10120-021-01167-8","article-title":"Hospital volume following major surgery for gastric cancer determines in-hospital mortality rate and failure to rescue: a nation-wide study based on German billing data (2009\u20132017)","volume":"24","author":"Diers","year":"2021","journal-title":"Gastric Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2026.112175_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/bjs5.103","article-title":"International comparison of treatment strategy and survival in metastatic gastric cancer","volume":"3","author":"Claassen","year":"2019","journal-title":"BJS Open"},{"issue":"11","key":"10.1016\/j.ejso.2026.112175_bib35","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/bjs.5863","article-title":"Learning curve of combined modality treatment in peritoneal surface disease","volume":"94","author":"Smeenk","year":"2007","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.ejso.2026.112175_bib36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.6004\/jnccn.2024.7013","article-title":"Systemic treatment strategies and outcomes of patients with synchronous peritoneal metastases of gastric origin: a nationwide population-based Study","volume":"22","author":"Guchelaar","year":"2024","journal-title":"JNCCN Journal of the National Comprehensive Cancer Network"},{"issue":"10294","key":"10.1016\/j.ejso.2026.112175_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2026.112175_bib38","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Korea","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejso.2026.112175_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2026.112175_bib41","first-page":"10","article-title":"Associations of education level with survival outcomes and treatment receipt in patients with gastric adenocarcinoma","author":"Xu","year":"2022","journal-title":"Front Public Health"},{"issue":"6","key":"10.1016\/j.ejso.2026.112175_bib42","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000362625","article-title":"Influence of socioeconomic status on survival and clinical outcomes in patients with advanced gastric cancer after chemotherapy","volume":"37","author":"Choi","year":"2014","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.ejso.2026.112175_bib43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.canep.2017.12.008","article-title":"Patient education-level affects treatment allocation and prognosis in esophageal- and gastroesophageal junctional cancer in Sweden","volume":"52","author":"Linder","year":"2018","journal-title":"Cancer Epidemiol"},{"issue":"23","key":"10.1016\/j.ejso.2026.112175_bib44","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1200\/JCO.18.01688","article-title":"Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis","volume":"37","author":"Bonnot","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.112175_bib45","first-page":"242","article-title":"Hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric cancer with peritoneal metastasis - joint analysis of European GASTRODATA and American national cancer database","author":"Pelc","year":"2025","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejso.2026.112175_bib46","series-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer. World Journal of Gastroenterology","first-page":"1114","author":"Seshadri","year":"2016"},{"issue":"9","key":"10.1016\/j.ejso.2026.112175_bib47","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/bjs.4164","article-title":"Prospective study of peritoneal recurrence after curative surgery for gastric cancer","volume":"90","author":"Roviello","year":"2003","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2026.112175_bib48","series-title":"GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study","author":"Glehen","year":"2014"},{"issue":"1","key":"10.1016\/j.ejso.2026.112175_bib49","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-021-08872-8","article-title":"Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II\/III adenocarcinoma \u2013 the phase III \u201cPREVENT\u201d- (FLOT9) trial of the AIO\/CAOGI\/ACO","volume":"21","author":"G\u00f6tze","year":"2021","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2026.112175_bib50","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-022-06880-y","volume":"23","author":"Di Giorgio","year":"2022","journal-title":"Trials"},{"key":"10.1016\/j.ejso.2026.112175_bib51","series-title":"Prophylactic preoperative HIPEC in advanced gastric cancer at high risk of peritoneal recurrence (CHIMERA)","author":"Pach","year":"2021"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326007948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326007948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:36:37Z","timestamp":1790894197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326007948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0748798326007948"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112175","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) versus palliative chemotherapy for peritoneal metastasized gastric cancer: a propensity score matched analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"112175"}}